These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 26590432)

  • 21. RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites.
    Campo JJ; Aponte JJ; Skinner J; Nakajima R; Molina DM; Liang L; Sacarlal J; Alonso PL; Crompton PD; Felgner PL; Dobaño C
    Mol Cell Proteomics; 2015 Mar; 14(3):519-31. PubMed ID: 25547414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Delay in the Licensing of Protozoal Vaccines: A Comparative History.
    Palatnik-de-Sousa CB; Nico D
    Front Immunol; 2020; 11():204. PubMed ID: 32210953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malaria vaccines and human immune responses.
    Long CA; Zavala F
    Curr Opin Microbiol; 2016 Aug; 32():96-102. PubMed ID: 27262417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes].
    Uyar Y; Akşit A; Karaca S; Ceylan ŞS; Yürük M
    Mikrobiyol Bul; 2017 Jan; 51(1):41-51. PubMed ID: 28283009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites.
    Atre T; Robinson TM; Savransky T; Dutta S; Epstein JE; Bergmann-Leitner ES
    Malar J; 2019 May; 18(1):186. PubMed ID: 31142328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection.
    Foquet L; Hermsen CC; van Gemert GJ; Van Braeckel E; Weening KE; Sauerwein R; Meuleman P; Leroux-Roels G
    J Clin Invest; 2014 Jan; 124(1):140-4. PubMed ID: 24292709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of malaria vaccines that block transmission of parasites by mosquito vectors.
    Hisaeda H; Yasutomo K
    J Med Invest; 2002 Aug; 49(3-4):118-23. PubMed ID: 12323000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap.
    Kaslow DC; Biernaux S
    Vaccine; 2015 Dec; 33(52):7425-32. PubMed ID: 26431982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses.
    White M; Amino R; Mueller I
    Trends Parasitol; 2017 Apr; 33(4):260-263. PubMed ID: 28077251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria.
    Stanisic DI; Ho MF; Nevagi R; Cooper E; Walton M; Islam MT; Hussein WM; Skwarczynski M; Toth I; Good MF
    mBio; 2021 Oct; 12(5):e0265721. PubMed ID: 34663097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria vaccine: a bright prospect for elimination of malaria.
    Bairwa M; Rajput M; Khanna P; Rohilla R; Verma R; Chawla S
    Hum Vaccin Immunother; 2012 Jun; 8(6):819-22. PubMed ID: 22739688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The malaria vaccine--status quo 2013.
    Heppner DG
    Travel Med Infect Dis; 2013; 11(1):2-7. PubMed ID: 23454205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages.
    Nardin EH; Nussenzweig RS
    Annu Rev Immunol; 1993; 11():687-727. PubMed ID: 8476576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances and challenges in malaria vaccine development.
    Wang R; Smith JD; Kappe SH
    Expert Rev Mol Med; 2009 Dec; 11():e39. PubMed ID: 20003658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines for preventing malaria (pre-erythrocytic).
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD006198. PubMed ID: 17054280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of a plasmid DNA vaccine encoding 42kDa fragment of Plasmodium vivax merozoite surface protein-1.
    Sheikh IH; Kaushal DC; Chandra D; Kaushal NA
    Acta Trop; 2016 Oct; 162():66-74. PubMed ID: 27311385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress in the development of recombinant and synthetic blood-stage malaria vaccines.
    Mahanty S; Saul A; Miller LH
    J Exp Biol; 2003 Nov; 206(Pt 21):3781-8. PubMed ID: 14506213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
    D'Alessandro U; Leach A; Drakeley CJ; Bennett S; Olaleye BO; Fegan GW; Jawara M; Langerock P; George MO; Targett GA
    Lancet; 1995 Aug; 346(8973):462-7. PubMed ID: 7637479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study.
    Stanisic DI; Fink J; Mayer J; Coghill S; Gore L; Liu XQ; El-Deeb I; Rodriguez IB; Powell J; Willemsen NM; De SL; Ho MF; Hoffman SL; Gerrard J; Good MF
    BMC Med; 2018 Oct; 16(1):184. PubMed ID: 30293531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.